| 标题 |
Etirinotecan pegol (NKTR-102) versus treatment of physician's choice in women with advanced breast cancer previously treated with an anthracycline, a taxane, and capecitabine (BEACON): a randomised, open-label, multicentre, phase 3 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet Oncology 作者:E. Perez; A. Awada; J. O'Shaughnessy; H. Rugo; C. Twelves; et al 出版日期:2015-11-01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)